KIR3DP1

Across TCGA pan-cancer cohorts, KIR3DP1 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated KIR3DP1 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher KIR3DP1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated KIR3DP1 expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

KIRP, COAD, and KIRC are the cancer types where KIR3DP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Tertile	All	0.038	0.920	<.001	66	view →
COAD	OS	Tertile	All	0.116	0.666	.027	39	view →
KIRC	DFS	Tertile	All	0.270	0.799	<.001	36	view →
DLBC	OS	Tertile	All	0.053	0.936	<.001	36	view →
MESO	DFS	Tertile	II,III,IV	0.077	0.412	<.001	36	view →
SARC	DFS	Tertile	All	0.089	0.611	<.001	36	view →
BLCA	DFS	Tertile	All	0.153	0.615	.020	27	view →
HNSC	DFS	Tertile	III,IV	1.000	0.558	.044	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

KIR3DP1–KIRP (DFS)

Open the KIRP breakdown →